Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents.

[1]  Kentaro Kato,et al.  Cloning of the genome of equine herpesvirus 4 strain TH20p as an infectious bacterial artificial chromosome , 2009, Archives of Virology.

[2]  H. Field,et al.  Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase. , 2008, Antiviral research.

[3]  H. Field.  Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile (2nd Edition) , 2008, Antiviral chemistry & chemotherapy.

[4]  Ying Huang,et al.  A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. , 2008, Journal of virological methods.

[5]  E. Thiry,et al.  The order Herpesvirales , 2008, Archives of Virology.

[6]  H. Nauwynck,et al.  Pharmacokinetics of Acyclovir after Intravenous Infusion of Acyclovir and after Oral Administration of Acyclovir and Its Prodrug Valacyclovir in Healthy Adult Horses , 2007, Antimicrobial Agents and Chemotherapy.

[7]  H. Nauwynck,et al.  In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet. , 2007, Veterinary microbiology.

[8]  R. Eberle,et al.  Sensitivity of Monkey B Virus (Cercopithecine herpesvirus 1) to Antiviral Drugs: Role of Thymidine Kinase in Antiviral Activities of Substrate Analogs and Acyclonucleosides , 2007, Antimicrobial Agents and Chemotherapy.

[9]  G. Boivin,et al.  Thymidine Kinase Mutations Conferring Acyclovir Resistance in Herpes Simplex Type 1 Recombinant Viruses , 2006, Antimicrobial Agents and Chemotherapy.

[10]  N. Pusterla,et al.  Equine Herpesvirus 1 and 4 Respiratory Disease in the Horse , 2006 .

[11]  W. D. Wilson,et al.  Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June 2004. , 2006, Veterinary immunology and immunopathology.

[12]  H. Nauwynck,et al.  In vitro comparison of antiviral drugs against feline herpesvirus 1 , 2006, BMC veterinary research.

[13]  J. von Einem,et al.  Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. , 2006, BioTechniques.

[14]  J. Heldens,et al.  Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review. , 2005, Veterinary journal.

[15]  S. Kit,et al.  Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves , 2005, Archives of Virology.

[16]  R. Toribio,et al.  Equine herpesvirus 1 and 4. , 2004, The Veterinary clinics of North America. Equine practice.

[17]  H. Jenssen,et al.  A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. , 2004, Antiviral research.

[18]  K. Maeda,et al.  Development of an Equine Herpesvirus Type 4-Specific Enzyme-Linked Immunosorbent Assay Using a B-Cell Epitope as an Antigen , 2004, Journal of Clinical Microbiology.

[19]  K. Smith,et al.  In vitro characterisation of high and low virulence isolates of equine herpesvirus-1 and -4. , 2003, Research in veterinary science.

[20]  H. Nauwynck,et al.  A local epidemic of equine herpesvirus 1-induced neurological disorders in Belgium , 2003 .

[21]  D. Thouvenot,et al.  Herpes simplex virus resistance to antiviral drugs. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[22]  I. Mo,et al.  Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene , 2002, Archives of Virology.

[23]  N. Heintz,et al.  Bac to the future: The use of bac transgenic mice for neuroscience research , 2001, Nature Reviews Neuroscience.

[24]  D. Court,et al.  A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. , 2001, Genomics.

[25]  H. Shizuya,et al.  The development and applications of the bacterial artificial chromosome cloning system. , 2001, The Keio journal of medicine.

[26]  C. Crumpacker,et al.  A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical Isolates , 2000, Antimicrobial Agents and Chemotherapy.

[27]  G. Jahn,et al.  A simple and rapid method for preparation of viral DNA from cell associated cytomegalovirus. , 1999, Journal of virological methods.

[28]  E. Telford,et al.  The DNA sequence of equine herpesvirus-4. , 1998, The Journal of general virology.

[29]  A. Balows,et al.  Topley & Wilson`s microbiology and microbial infections , 1998 .

[30]  E. Clercq.  Trends in the development of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retroviruses , 1995 .

[31]  H. Field,et al.  Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals. , 1993, The Journal of general virology.

[32]  S. Safrin,et al.  Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern , 1993 .

[33]  T. Matsumura,et al.  Epizootiological aspects of type 1 and type 4 equine herpesvirus infections among horse populations. , 1992, The Journal of veterinary medical science.

[34]  S. Kit,et al.  Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses. , 1990, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[35]  K. Tyler,et al.  Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Field,et al.  Analysis of the bovine herpesvirus type 1 thymidine kinase (TK) gene from wild-type virus and TK-deficient mutants. , 1989, The Journal of general virology.

[37]  Bryans Jt,et al.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. , 1986 .

[38]  L. Stanberry,et al.  Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs , 1985, Journal of virology.

[39]  A. Kaplan,et al.  Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. , 1985, American journal of veterinary research.

[40]  S. Kit,et al.  Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus. , 1985, American journal of veterinary research.

[41]  E. Rollinson,et al.  Relative activities of acyclovir and BW759 against Aujeszky's disease and equine rhinopneumonitis viruses. , 1983, Antimicrobial Agents and Chemotherapy.

[42]  H. Field,et al.  The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice , 1978, Journal of Hygiene.

[43]  R. Ishizaki,et al.  Etiologic study on an outbreak of acute respiratory disease among colts due to equine rhinopneumonitis virus. , 1962, The Japanese journal of experimental medicine.